semaglutide and antipsychotics in Patients With Schizophrenia, Prediabetes, Obesity 🚨 1. Semaglutide significantly improved insulin sensitivity, reduced insulin resistance, lowered fasting glucose, and promoted substantial weight loss in patients with antipsychotic Management of obesity with semaglutide

The [elderly] community is very interested in GLP-1, both from the weight loss perspective, but also [when it comes to] the reduction of inflammation, which also seems to drive part of aging

Most patients are advised to maintain a stable weight for several months before pursuing facial surgery, body contouring, or breast procedures

Oat Beta Glucan Oat beta glucan is a soluble, viscous fiber derived from oat cell walls that supports healthy post-meal metabolic responses

Biomed Pharmacother 91:378384 Haddad R, Elisei R, Hoff A (2023) Diagnosis and management of tropomyosin receptor kinase fusion-positive thyroid carcinomas

For some people, though, when prescribed for specific medical conditions, insurance will provide partial reimbursement

Meet the weight-management clinical criteria (measured at the time GLP-1 therapy was first started): BMI of 35 or higher, or BMI of 30 or higher with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or chronic kidney disease (stage 3a or above), or BMI of 27 or higher with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease